The rat mammary gland: Morphologic changes as an indicator of systemic hormonal perturbations induced by xenobiotics

Toxicologic Pathology

Volumn 35, Issue 2, 2007, Pages 199-207

  Lucas, Julia N ^a   Rudmann, Daniel G ^b   Credille, Kelly M ^b   Irizarry, Armando R ^b   Peter, Augustine ^a   Snyder, Paul W ^a  

^a PURDUE UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Endocrine disrupters; Mammary gland; Preclinical safety assessment risk management; Rat pathology; Reproductive system; Toxicologic pathology; Xenobiotics

Indexed keywords

ANDROGEN; DOPAMINE RECEPTOR BLOCKING AGENT; ESTRADIOL; ESTROGEN DERIVATIVE; FLUTAMIDE; FULVESTRANT; GROWTH HORMONE; METOCLOPRAMIDE; MIFEPRISTONE; PROGESTERONE; PROLACTIN; RECOMBINANT GROWTH HORMONE; TAMOXIFEN; TESTOSTERONE; XENOBIOTIC AGENT;

ATROPHY; BREAST ATROPHY; BREAST HYPERPLASIA; FEMINIZATION; GENE DELETION; MAMMARY GLAND; MORPHOLOGY; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; RAT STRAIN; REVIEW; VIRILIZATION;

ANDROGENS; ANIMALS; ENDOCRINE SYSTEM; ESTROGENS; FEMALE; GROWTH HORMONE; HORMONES; MALE; MAMMARY GLANDS, ANIMAL; PROGESTERONE; PROLACTIN; RATS; XENOBIOTICS;

RATTUS;

EID: 33847786009     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1080/01926230601156260     Document Type: Review

References (67)

1. Ahren, K., and Etieinne, M. (1957). The development of the mammary gland in normal and castrated male rats after the age of 21 days. Acta Physiol Scand 41(2-3), 283-300.
2. Astwood, E. B., Geschickter, C. F., and Rausch, E. O. (1937). Development of the mammary gland of the rat. Amer J Anat 61, 373-405.
3. Atwood, C. S., Hovey, R. C., Glover, J. P., Chepko, G., Ginsburg, E., Robison, W. G., and Vonderhaar, B. K. (2000). Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. J Endocrinol 167(1), 39-52.
4. Ben-Jonathon, N., Mershon, J. L., Allen, D. L., and Steinmetz, R. W. (1996). Extrapituitary prolactin: distribution, regulation, functions and clinical aspects. Endocr Rev 17, 639-69.
5. Biegel, L. B., Cook, L. C., Hurtt, M. E., and O'Connor, J. C. (1998). Effects of 17 beta-estradiol on serum hormone concentrations and estrous cycle in female Crl:CD BR rats: effects on parental and first generation rats. Toxicol Sci 44, 143-54.
6. Biegel, L. B., Flaws, J. A., Hirshfield, A. N., O'Connor, J. C., Elliott, G. S., Ladics, G. S., Silbergeld, E. K., Van Pelt, C. S., Hurtt, M. E., Cook, J. C., and Frame, S. R. (1998). 90-day feeding and one-generation reproduction study in Crl:CD BR rats with 17b-estradiol. Toxicol Sci 44, 116-42.
7. Brisken, C., Kaur, S., Chavarria, T. E., Binart, N., Sutherland, R. L., Weinberg, R. A., Kelly, P. A., and Ormandy, C. J. (1999). Prolactin controls mammary gland development via direct and indirect mechanisms. Develop Biol 210(1), 96-106.
8. Cardy, R. H. (1991). Sexual dimorphism of the normal rat mammary gland. Vet Pathol 28(2), 139-45.
9. Carsol, J. L., Gingras, S., and Simard, J. (2002). Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor. Mol Endocrinol 16(7), 1696-710.
10. Ceriani, R. L. (1970). Fetal mammary gland differentiation in vitro in response to hormones. II. Biochemical findings. Develop Biol 21(4), 530-46.
11. Conneely, O. M., Mulac-Jericevic, B., DeMayo, F., Lydon, J. P., and O'Malley, B. W. (2002). Reproductive functions of progesterone receptors. Recent Progr Hormone Res 57, 339-55.
12. Cook, J. C., Johnson, L., O'Connor, J. C., Biegel, L. B., Krams, C. H., Frame, S. R., and Hurtt, M. E. (1998). Effects of dietary 17b-estradiol exposure on serum hormone concentrations and testicular parameters in male Crl:CD BR rats. Toxicol Sci 44, 155-68.
13. Cowie, A. T., and Folley, S. J. (1961). The mammary gland and lactation In: Sex and Internal Secretion, vol 1, 3rd ed. (W. C. Young, ed), pp 590-641, Williams and Wilkins, Baltimore.
14. Daniel, C.W., and Silberstein G. B. (1987). Postnatal development of the rodent mammary gland. In: The Mammary Gland: Development, Regulation and Function (M. C. Neville and C. W. Daniel, eds.), pp 1-36, Plenum Press, New York.
15. Feldman, M., Ruan, W., Cunningham, B. C., Wells, J. A., and Kleinberg, D. L. (1993). Evidence that the growth hormone receptor mediates differentiation and development of the mammary gland. Endocrinology 133(4), 1602-8.
16. Fernandez-Valdivia, R., Mukherjee, A., Mulac-Jericevic, B., Conneely, O. M., DeMayo, F. J., Amato, P., andLydon, J. P. (2005). Revealing progesterone's role in uterine and mammary gland biology: insights from the mouse. Sem Reproduct Med 23(1), 22-37.
17. Freeman, C. S., and Topper, Y. J. (1978). Progesterone and glucocorticoid in relation to the growth and differentiation of mammary epithelium. J Toxicol Environ Health 4(2-3), 269-82.
18. Gallego, M. I., Binart, N., Robinson, G. W., Okagaki, R., Coschigano, K. T., Perry, J., Kopchick, J .J., Oka, T., Kelly, P. A., and Hennighausen, L. (2001). Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Develop Biol 229(1), 163-75.
19. Goldman, A. S., Shapiro, B., and Neumann, F. (1976). Role of testosterone and its metabolites in the differentiation of the mammary gland in rats. Endocrinology 99(6), 1490-5.
20. Greaves, P., Goonetilleke, R., Nunn, G., Topham, J., and Orton, T. (1993). Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. Cancer Res. 53(17), 3919-24.
21. Harris, J., Stanford, P. M., Oakes, S. R., and Ormandy, C. J. (2004). Prolactin and the prolactin receptor: new targets of an old hormone. Ann Med. 36(6), 414-25.
22. Hovey, R. C., McFadden, T. B., and Akers, R. M. (1999). Regulation of mammary gland growth and morphogenesis by the mammary fat pad: a species comparison. J Mamm Gland Biol Neoplasia 4(1), 53-68.
23. Imagawa, W., Pedchenko, V. K., Helber, J., and Zhang, H. (2002). Hormone/ growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis. J Ster Biochem Mol Biol 80(2), 213-30.
24. Jorgensen, K. D., Svendsen, O., Greenough, R. J., Kallesen, T., Goburdhun R., Skydsgaard, K., Finch, J., Dinesen, B., and Nilsson, P. (1988). Biosynthetic human growth hormone: subchronic toxicity studies in rats and monkeys. Pharm Toxicol 62, 329-33.
25. Kamiya, K., Gould, M. N., and Clifton, K. H. (1998). Quantitative studies of ductal versus alveolar differentiation from rat mammary clonogens. Proc Soc Exper Biol & Med 219(3), 217-25.
26. Karlsson, S., Hirsimaki,Y., Mantyla, E., Nieminen, L., Kangas, L., Hirsimaki, P., Perry C. J., Mulhern, M., Millar, P., Handa, J., andWilliams, G. M. (1996). A two-year dietary carcinogenicity study of the antiestrogen toremifene in Sprague-Dawley rats. Drug Chem Toxicol 19, 245-66.
27. Kennel, P., Pallen, C., Barale-Thomas, E., Espuna, G., and Bars, R. (2003). Tamoxifen: 28-day oral toxicity study in the rat based on the enhanced OECD test guideline 407 to detect endocrine effects. Arch Toxicol 77, 487-99.
28. Kleinberg, D. L. (1997). Early mammary development: growth hormone and IGF-1. J Mamm Gland Biol Neoplasia 2(1), 49-57.
29. Kleinberg D. L., Ruan, W., Catanese, V., Newman, C. B., and Feldman, M. (1990). Non-lactogenic effects of growth hormone on growth and insulinlike growth factor-I messenger ribonucleic acid of rat mammary gland. Endocrinology 126(6), 3274-6.
30. Knight, C. H., and Peaker, M. (1982). Development of the mammary gland. J Reproduct Fertil 65(2), 521-36.
31. Laqueur, G. L., and Fluhmann, C. F. (1942). Effects of testosterone propionate in immature and adult female rats. Endocrinology 30, 93-101.
32. Lewis, A. A., Gomez, E. T., and Turner, C.W. (1942). Mammary gland development with mammogen I in the castrated and the hypophysectomized rat. Endocrinology 30, 34-47.
33. Lkhider, M., Delpal, S., Le Provost, F., and Ollivier-Bousquet, M. (1997). Rat prolactin synthesis by lactating mammary epithelial cells. FEBS Lett 401(2-3), 117-22.
34. Lotz,W., and Krause, R. (1978). Correlation between the effects of neuroleptics on prolactin release, mammary stimulation and the vaginal cycle in rats. J Endocr 76, 507-15.
35. Masso-Welch, P. A., Darcy, K. M., Stangle-Castor, N. C., and Ip, M. M. (2000). A developmental atlas of rat mammary gland histology. J Mamm Gland Biol Neoplasia 5(2), 165-85.
36. Myers, J. A. (1917). Studies of the mammary gland II. The fetal development of the mammary gland in the female albino rat. Amer J Anat 22, 195-223.
37. Nolin, J. M., Campbell, G. T., Nansel, D. D., and Bogdanove, E.M. (1977). Does androgen influence prolactin secretion? Endocr Res Comm 4, 61-70.
38. O'Connor, J. C., Cook, J. C., Craven, S. C., Van Pelt, C. S., and Obourn, J. D. (1996). An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators. Fund Appl Toxicol 33, 182-95.
39. O'Connor, J. C., Davis, L. G., Frame, S. R., and Cook, J. C. (2000). Evaluation of a Tier 1 screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486. Toxicol Sci 54, 338-54.
40. O'Connor, J. C., Frame, S. R., Biegel, L. B., Cook, J. C., and Davis, L. G. (1998). Sensitivity of a Tier I screening battery compared to an in utero exposure for detecting the estrogen receptor agonist 17 beta-estradiol. Toxicol Sci 44, 169-84.
41. O'Connor, J. C., Frame, S. R., and Ladics, G. S. (2002). Evaluation of a 15-day screening assay using intact male rats for identifying steroid biosynthesis inhibitors and thyroid modulators. Toxicol Sci 69, 79-91.
42. O'Connor, J. C., Frame, S. R., and Ladics G. S. (2002). Evaluation of a 15-day screening assay using intact male rats identifying antiandrogens. Toxicol Sci 69, 92-108.
43. Oka, T., and Topper, Y. J. (1972). Is prolactin mitogenic for mammary epithelium? Proc Natl Acad Sci USA 69(7), 1693-6.
44. Peckham,W. D., Hotchkiss, J., Knobil, E., and Nicoll, C. S. (1968). Prolactin activity of homogenous primate growth hormone preparations. Endocrinology 82, 1247.
45. Reece, R. P., Turner, C.W., and Hill, R. T. (1936). Mammary gland development in the hypophysectomized albino rat. Proc Soc Exp Biol Med 34, 204-17.
46. Richert, M. M., andWood,T. L. (1999).The insulin-like growth factors (IGF) and IGF type I receptor during postnatal growth of the murine mammary gland: sites of messenger ribonucleic acid expression and potential functions. Endocrinology 140(1), 454-61.
47. Ruan,W., and Kleinberg, D. L. (1999). Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 140(11), 5075-81.
48. Ruan,W., Monaco, M. E., and Kleinberg, D. L. (2005). Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action. Endocrinology 146(3), 1170-8.
49. Ruan, W., Newman, C. B, and Kleinberg, D. L. (1992). Intact and aminoterminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc Natl Acad Sci USA 89(22), 10872-6.
50. Ruan, W., Catanese, V., Wieczorek, R., Feldman, M., and Kleinberg, D. L. (1995). Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid. Endocrinology 136(3), 1296-302.
51. Ruiz, A., Aguilar, R., Tebar, M., Gaytan, F., and Sanchez-Criado, J. E. (1996). RU486-treated rats show endocrine and morphologic responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies. Biol Reprod 55, 1284-91.
52. Rudmann, D. G., Cohen, I. R., Robbins, M. R., Coutant, D. E., and Henck, J. W. (2005). Androgen dependent mammary gland virilism in rats given the selective estrogen receptor modulator LY2066948 hydrochloride. Toxicol Pathol 33(6), 711-19.
53. Russo, I. H., Pokorzynski, T., and Russo, J. (1986). Asynchronous development of the rat mammary glands: a determining factor in carcinogenesis. Breast Cancer Res Treat 8, 118a.
54. Russo, I. H., Gimotty, P., Dupuis, M., and Russo, J. (1989a). Effect of medoxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis. Brit J Canc 59(2), 210-16.
55. Russo, I. H., Medado, J., and Russo, J. (1989b). Endocrine Influences on the Mammary Gland. In: Monographs on Pathology of Laboratory Animals (T. C. Jones, U. Mohr, and R. D. Hunt, eds), p. 33, Springer-Verlag, Berlin.
56. Russo, I. H., Tewari, M., and Russo, J. (1989c). Morphology and development of the rat mammary gland. In: Monographs on Pathology of Laboratory Animals (T. C. Jones, U. Mohr, and R. D. Hunt, eds.), p. 233, Springer-Verlag, Berlin.
57. Selye, H., McEuen, C. S., and Collip, J. B. (1936). Effect of testosterone on the mammary gland. Proceedings of the Society of Experimental Biology 34, 201-203.
58. Shyamala, G. (1999). Progesterone signaling and mammary gland morphogenesis. J Mamm Gland Biol Neoplasia 4(1), 89-104.
59. Shyamala, G., Louie, S. G., Camarillo, I. G., and Talamantes, F. (1999). The progesterone receptor and its isoforms in mammary development. Mol Genet Metabol 68(2), 182-90.
60. Silberstein, G. B. (2001). Postnatal mammary gland morphogenesis. Microsc Res Techn 52(2), 155-62.
61. Sourla, A., Martel, C., Labrie, C., and Labrie, F. (1998). Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland. Endocrinology 139(2), 753-64.
62. Sourla, A., Flamand, M., Belanger, A., and Labrie, F. (1998). Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat. J Steroid Biochem Mol Biol 66(3), 137-49.
63. Topper, Y. J., and Freeman, C. S. (1980). Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60(4), 1049-106.
64. Topper, Y. J., Oka, T., Owens, I. S., and Vonderhaar, B. K. (1972). Some aspects of mouse mammary gland development from maturity to early pregnancy. In Vitro 8(3), 228-36.
65. Toyoda, K., Shibutani, M., Tamura, T., Koujitani, T., Uneyama, C., and Hirose, M. (2000). Repeated dose (28 days) oral toxicity study of flutamide in rats, based on the draft protocol for the 'Enhanced OECD Test Guideline 407' for screening endocrine-disrupting chemicals. Arch Toxicol 74, 127-32.
66. Van Der Schoot, P., Bakker, G. H., and Klijn, J. G. M. (1987). Effects of the progesterone antagonist RU486 on ovarian activity in the rat. Endocrinology 121, 1375-82.
67. Wang, X. J., Bartolucci-Page, E., Fenton, S. E., and You, L. (2005). Altered mammary gland development in male rats exposed to genistein and methoxychlor. Toxicol Sci 91, 93-103.